Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models.
Tejin Intelligence
Series B in 2025
Tejin Intelligence is deeply involved in radio sensing and spectrum big data analysis technology, and is dedicated to providing the world's leading low-altitude safety management and control solutions, assisting in the development of new ground-air integrated three-dimensional security infrastructure for smart cities, and striving for refined management of urban low-altitude airspace.
Zhongtiansheng New Materials
Series A in 2025
Zhongtiansheng New Materials is a polyimide monomer and resin production company. It also manufactures resin material composites and liquid crystal orientation agents.
Mingxin Digital
Series B in 2025
Mingxin Digital is a financial technology company focused on enhancing industrial credit management through digital solutions. It has developed a software-as-a-service (SaaS) platform designed for corporate credit evaluation management. This platform serves as a comprehensive tool for assessing business operations, enabling companies to improve their operational efficiency and strengthen their risk management capabilities. By leveraging digital technology, Mingxin Digital aims to facilitate better credit management practices within various industries.
AusperBio
Series B in 2024
AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligoâ„¢ ASO platform, AusperBio aims to deliver effective targeted therapies that leverage antisense oligonucleotide technology. The company is dedicated to transforming the treatment landscape for hepatitis B, with an emphasis on finding a cure and providing protection through novel therapeutic approaches. Additionally, AusperBio's research extends to addressing a variety of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, thereby broadening the potential impact of its therapeutic innovations.
Mianbi Smart
Venture Round in 2024
Mianbi Smart enables large-scale model acceleration and application execution using artificial intelligence.
Ultron Photonics
Series C in 2024
Ultron Photonics Inc. is a manufacturer based in Hangzhou, China, specializing in ultra-short-pulse laser systems and their core components. Founded in 2018, the company produces femtosecond lasers, laser oscillators, and associated modules that are vital for various applications. Its products support sectors such as 3C electronics, solar cell manufacturing, micro-fine metal processing, precision surgery, biological imaging, ultrafast spectroscopy, terahertz imaging, and avionics. Ultron Photonics is dedicated to enhancing manufacturing processes by providing reliable and stable ultrafast laser solutions that improve efficiency and productivity.
Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models.
Weimai Medical
Series A in 2024
Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Yida Technology
Series B in 2024
Yida Technology is engaged in technologies to create digital robots, empower users to realize business hyper-automation and build a future digital intelligence world. It has original and self-developed core technologies in related fields such as digital robots, artificial intelligence, and big data mining.
Spear Bio
Series A in 2024
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.
ReviR Therapeutics
Series A in 2024
ReviR Therapeutics is a genomics-focused company that specializes in the development of RNA therapeutics aimed at treating cancer, rare genetic disorders, and infectious diseases. The company utilizes an artificial intelligence-driven platform to enhance the discovery of novel RNA-targeting medicines, thereby facilitating the delivery of innovative therapies to a wide patient population. ReviR Therapeutics combines advanced computational techniques with its expertise in RNA biology, positioning itself as a leader in the evolving field of RNA-based therapeutics.
Huantian Wisdom
Series B in 2024
Huantian Wisdom is an integrated provider of smart city solutions that focuses on developing innovative infrastructure for urban environments. The company specializes in environmentally friendly street lighting systems designed to enhance green infrastructure. By leveraging both satellite and ground technologies, Huantian Wisdom aims to create sustainable urban ecosystems that benefit residents and improve the overall quality of life in cities. Through its commitment to smart technology and sustainable practices, the company contributes to the advancement of modern urban living.
CuPure Biotechnology
Seed Round in 2024
CuiPure Biotechnology is a developer of purification processes and materials for cell gene therapy, overcoming technical difficulties in molds, fluid mechanics, material synthesis, and bioengineering. They aim to improve resolution, binding capacity, processing speed, and filler costs for large-scale industrial purification.
OxSyns Biotech
Series A in 2024
OxSyns Biotech specializes in chemical synthesis and bioelectrochemical sensing for the chemical industry.
Ruijiakang
Series A in 2024
Ruijiakang focuses on the research, development, and application of green synthetic biology production, as well as the layout and research of biofuels and biomaterials for non-grain anaerobic organic alkyd pipelines, and employs Zymomonas mobilis.
Bach Hoa Xanh
Secondary Market in 2024
Bach Hoa Xanh is a chain of minimarts and food stores that concentrate in fresh produce and everyday household necessities.
PRCXI Biotechnology
Seed Round in 2024
PRCXI Biotechnology is a biotech company that provides bioinformatics and automation solutions for life science and the manufacturing of analytical instruments.
CYGNUSEMI
Series B in 2024
Cygnus Semi is a semiconductor chip technology company that specializes in developing solutions for 5G Internet-of-Things (IoT) applications. The company focuses on creating advanced connectivity capabilities for smart devices and smart cities. Its products are designed to enhance the performance of electronic devices, allowing manufacturers to integrate high-quality chip technology into their smart products. Through its innovations, Cygnus Semi aims to support the growing demand for enhanced connectivity in various sectors.
Curium Strontium
Venture Round in 2024
Curium Strontium is a CNC machine tool equipment developer that specializes in R&D, production, and sales of CNC machines. It also offers samples such as cover electrodes, shell models, micro-hole precision machining, bowl-shaped turning components, and graphite processing, and is dedicated to supplying industry users with associated gear, equipment, and services.
Weimai Medical
Series A in 2024
Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Volant Aerotech
Series A in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Yuansuan Technology
Series C in 2024
Yuansuan Technology specializes in enhancing the digital research and development processes for industrial goods, alongside offering digital management and maintenance solutions for facilities and equipment through local simulation software. The company also develops cloud architecture technology that delivers cloud computing services tailored for various enterprise sectors, including automobile transportation, energy, hydraulic emergency response, and machinery manufacturing. Their offerings encompass cloud entry services, comprehensive cloud solutions, and operational maintenance services, all aimed at improving cloud operational efficiency for their clients.
Greenon Biotech
Seed Round in 2024
Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Snow Tech
Seed Round in 2024
Snow Tech specializes in providing digital security products and services tailored for enterprise cybersecurity. The company develops a network security access architecture that employs a three-in-one service model, which includes product-based, security-centered, and operation-based guarantees. Its offerings encompass four core functions: context dynamic strategy, asset threat analysis, data security protection, and abnormal behavior analysis. Through these capabilities, Snow Tech enables enterprises to safeguard their digital assets, defend against external attacks, and identify internal security threats effectively. The company supports both local and Software as a Service (SaaS) deployment, addressing the diverse needs of its clients in an increasingly complex digital landscape.
Corerain Technologies
Series C in 2023
Corerain is an artificial intelligence company. They provide a next generation computing platform with integrated software and hardware development stacks to accelerate AI deployment in smart cities, aerospace, and smart manufacturing.
HemaCell is a biotechnology company specializing in cell therapy, specifically focused on regenerating hematopoietic lineages, which include blood and immune cells, through advanced in vitro techniques. Leveraging innovative stem cell reprogramming, editing, and differentiation technologies, HemaCell aims to address the critical shortage of platelets necessary for treating various diseases such as cancer, liver disease, critical illness, and hematological disorders. The company employs a unique platform that utilizes platelets as drug delivery carriers, facilitating the rapid establishment of induced pluripotent stem cells (iPSCs) and gene targeting technologies. In addition to platelet production, HemaCell is dedicated to developing novel therapeutic solutions for diseases associated with platelet abnormalities, thereby offering effective treatment options and addressing significant medical needs.
Agibot is a company that specializes in the development and manufacturing of humanoid robots powered by artificial intelligence. With a focus on industrial manufacturing applications, Agibot's robots are designed to perform a variety of real-world tasks, particularly in sectors such as 3C manufacturing and automotive production. The company's emphasis on fine-grained manipulation and collaborative capabilities enables its robots to enhance operational efficiency across multiple industries. Agibot is committed to continuous research and development, exploring new applications for its technology to address the increasing demand for automation and intelligent systems in the workforce. Through its innovative solutions, Agibot aims to contribute significantly to the evolution of robotics in everyday environments.
Gewei Semiconductor
Series B in 2023
Gewei Semiconductor is a manufacturer of efficient analog and analog-digital hybrid chips. It focuses mainly on the design and development of automotive-grade electric vehicle-specific chips.
Spear Bio
Seed Round in 2023
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.
Weiling Medical
Angel Round in 2023
Wiling Medical offers extensive knowledge of the principles and clinical uses of implantable brain-computer interfaces as well as extensive experience in basic research engineering practise, and clinical care.
Juyou Bio-tech
Angel Round in 2023
Juyou Bio-tech is a biotechnology company that develops, manufactures, and distributes synthetic biological raw materials, biomedical materials, and dermatology-grade skin care products. Its primary focus is on creating precise and effective treatments to address various skin problems, enabling consumers to repair and maintain healthy skin barriers.
Weixin New Materials
Series C in 2023
Weixin New Materials is a manufacturer specializing in photoresist resins and electronic-grade monomers, primarily serving the semiconductor industry. The company is dedicated to producing high-purity, low-cost, and environmentally-friendly materials that support advanced manufacturing processes. Through its focus on research and development, Weixin New Materials aims to provide innovative solutions tailored to the needs of its clients, enhancing the efficiency and quality of semiconductor production.
FreBang is a research and development company specializing in high-end functional nanomaterials. It focuses on the manufacture and sale of a diverse range of products, including nanofiber-based particle purification materials, antibacterial air purification materials, and electrostatic melt-blown fiber filters that offer high efficiency with low resistance. Additionally, the company develops gas pollutant catalytic decomposition materials and flexible ceramic nanofiber insulation materials designed to withstand high temperatures. FreBang's advanced nano-membrane solutions cater to various industries, including semiconductors, biomedicine, panels, aquaculture, lithium batteries, and aerospace applications, such as helicopters and missiles, as well as high-end outdoor clothing.
Shenzhen Jianwang Technology
Series A in 2023
Shenzhen Jianwang Technology is a high-tech enterprise dedicated to the development and manufacture of smart energy solutions, particularly in the realm of power electronics. The company specializes in smart grid technology and focuses on the research and production of charging pile power modules and both AC and DC charging piles. In addition to these products, Jianwang Technology provides comprehensive services related to the operation and maintenance of charging stations, as well as high-end power supply customization services. Through its innovative approach, the company aims to contribute significantly to the new energy sector.
Formal-Tech
Series A in 2023
Formal-Tech is an embedded system software company that specializes in the development, production, and sales of high-safety industrial control software and hardware.
Jiemeng Intelligence
Venture Round in 2023
Jiemeng Intelligence specializes in the development, design, and manufacturing of equipment for the lithium-ion battery industry, particularly in the coating process. The company is dedicated to providing innovative solutions for front-end equipment and lithium-ion battery machinery. Jiemeng Intelligence aims to deliver safe, efficient, and intelligent new energy equipment solutions to its clients, supporting advancements in energy technology.
Enigma is an innovative technology company dedicated to providing safe, reliable, and advanced solutions for industrial intelligent manufacturing.
Xincheng Semiconductor
Seed Round in 2023
Xincheng Semiconductor manufactures integrated circuit packaging substrates. Semiconductor is a provider of integrated circuit packaging substrate solutions. It focuses on the research and development and mass manufacture of high-density flip-chip packaging substrates, filling a gap in domestic high-end substrates and assisting the domestic semiconductor industry chain in becoming autonomous and controllable.
Mucheng Fireproof
Series A in 2023
Mucheng is a high-tech chemical enterprise focuses on special materials such as cutting-edge fire prevention, fire resistance and heat insulation.
Lanhai Energy
Seed Round in 2023
Lanhai Energy is a new energy storage solution provider that assists customers in achieving their ESG objectives. They provide commercial-scale ESS and EVCS systems that are distinguished by innovation and advanced technologies.
Acchrom, also known as Huapu Instrument (Beijing) Technology Co., Ltd., is a prominent company specializing in chromatography, offering comprehensive solutions that include products, technical services, and support. The company's focus is on chromatographic separation products designed to effectively separate mixtures. Acchrom emphasizes a closed-loop system that integrates chromatography equipment, consumables, software, and customer services, thereby enabling clients to conduct chromatographic separation analysis efficiently. The company is dedicated to establishing itself as a well-known national brand in chromatography and has developed targeted marketing strategies and a professional sales team across key provinces to enhance its marketing network and presence in the industry.
Edrive Space
Series B in 2023
Edrive Space specializes in the development of aerospace propulsion systems, focusing on electrothermal micro-propulsion technology. This innovative approach addresses the limitations of traditional electric propulsion systems, which often suffer from issues related to weight, power consumption, and thrust. Edrive Space's products are tailored for the rapid deployment and networking of micro-nano satellites, making them ideal for applications such as emergency collision avoidance of space debris and active deorbiting. The company's solutions are designed to meet the demands for low-cost, standardized, and batch-produced propulsion systems, thereby supporting the growth of the aerospace industry, particularly within China.
Ai Ma Biology
Angel Round in 2023
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.
Hualong is an industrial Internet empowerment platform that offers benefits in the realm of digital twins at the equipment, plant, and industrial levels.
Mingxin Digital
Series A in 2023
Mingxin Digital is a financial technology company focused on enhancing industrial credit management through digital solutions. It has developed a software-as-a-service (SaaS) platform designed for corporate credit evaluation management. This platform serves as a comprehensive tool for assessing business operations, enabling companies to improve their operational efficiency and strengthen their risk management capabilities. By leveraging digital technology, Mingxin Digital aims to facilitate better credit management practices within various industries.
Suzhou Keyang Semiconductor
Venture Round in 2023
Suzhou Keyang Semiconductor specializes in the design, research and development, manufacturing, packaging, and testing of semiconductor products, with a particular focus on through-silicon via (TSV) packaging and wafer-level chip-scale packages (WLCSP). The company provides comprehensive and innovative solutions, including bumping services, aimed at advancing the semiconductor industry. By offering a full suite of services from design to testing, Suzhou Keyang Semiconductor supports its clients in developing state-of-the-art integrated circuit products.
Yida Technology
Series B in 2023
Yida Technology is engaged in technologies to create digital robots, empower users to realize business hyper-automation and build a future digital intelligence world. It has original and self-developed core technologies in related fields such as digital robots, artificial intelligence, and big data mining.
Jinfang Pharmaceutical
Series C in 2023
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
Jidian Solar
Series A in 2023
Jidian Solar provides semiconductor materials and devices. They also provide research and development of perovskite technology services. Additionally, they also provide promoting energy transformation services.
Neomodulus
Series B in 2023
Nuoyimeier is a developer of implantable consumables.
Weiling Medical
Angel Round in 2023
Wiling Medical offers extensive knowledge of the principles and clinical uses of implantable brain-computer interfaces as well as extensive experience in basic research engineering practise, and clinical care.
Jinjing Keji
Series A in 2022
Jinjing Keji manufactures cathode fluorescence system products. They are mainly in scientific research institutes, semiconductor industry, and electron microscope manufacturing. They provide testing services too in addition to selling the product.
Chiral Quest
Series E in 2022
Chiral Quest is a company specializing in the development and supply of intermediates essential for the production of innovative pharmaceuticals. With a focus on chiral catalysts, Chiral Quest leverages the extensive process development experience of its chemists to transform laboratory-scale processes into practical, scalable manufacturing solutions. The firm is dedicated to delivering high-quality drug intermediates, catering primarily to the global generic drug industry. Through its commitment to cost-effective manufacturing, Chiral Quest plays a vital role in enhancing the efficiency and effectiveness of drug production.
Fabrie is a cloud-based collaboration software designed specifically for designers, focusing on enhancing team communication and idea development. The platform offers real-time synchronization, enabling multiple users to collaborate seamlessly. Fabrie is equipped with a variety of modifiable design templates, allowing users to easily start their projects without the frustration of navigating through non-editable resources. Additionally, it includes features for table and diagram associations, along with cloud storage and sharing capabilities, aimed at improving overall collaboration efficiency among design teams.
Well-Link Tech
Series B in 2022
Well-Link is a cloud rendering solutions provider with headquarters in Singapore.
Jiemeng Intelligence
Seed Round in 2022
Jiemeng Intelligence specializes in the development, design, and manufacturing of equipment for the lithium-ion battery industry, particularly in the coating process. The company is dedicated to providing innovative solutions for front-end equipment and lithium-ion battery machinery. Jiemeng Intelligence aims to deliver safe, efficient, and intelligent new energy equipment solutions to its clients, supporting advancements in energy technology.
Cims
Private Equity Round in 2022
CIMS Suzhou Co., Ltd. specializes in providing automated optical inspection solutions aimed at improving production processes and yield within the printed circuit board (PCB) manufacturing industry. Founded in 2005 and located in Suzhou, China, the company offers advanced technologies for various types of PCBs, including High Density Interconnect (HDI), flex, rigid-flex, and integrated circuit substrates. CIMS's solutions leverage sophisticated imaging and image processing technologies, addressing the specific needs of different segments of the PCB market. By enhancing production efficiency and product reliability, CIMS supports customers in adapting to the latest advancements in semiconductors and related technologies.
An Airgram is a real-time transcription with speaker identification and high-definition video recording.
Chuangjian Medical
Series A in 2022
Chuangjian Medical is a technological innovation company that focuses on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines.
Qingxin Technology
Series A in 2022
Zhejiang Qingxin is a manufacturer of semiconductor testing and sorting machines. It is involved in the research, development, and manufacture of most semiconductor automation equipment, with a focus on testing and packaging handling solutions.
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.
Weixin New Materials
Series B in 2022
Weixin New Materials is a manufacturer specializing in photoresist resins and electronic-grade monomers, primarily serving the semiconductor industry. The company is dedicated to producing high-purity, low-cost, and environmentally-friendly materials that support advanced manufacturing processes. Through its focus on research and development, Weixin New Materials aims to provide innovative solutions tailored to the needs of its clients, enhancing the efficiency and quality of semiconductor production.
Shanghai Linctex Digital Co., Ltd. specializes in software solutions for the fashion industry, focusing on three-dimensional (3D) design and collaboration. Founded in 2015 and based in Shanghai, the company offers a suite of services under the brand Style3D, which includes 3D modeling, physical simulation, and rendering tools tailored for fashion workflows. Their offerings encompass various functionalities such as three-dimensional pattern checking, component-based design, style management, and online style recommendations. Additionally, Linctex provides product data management solutions that facilitate resource accumulation, cost accounting, and bill of materials generation. The company also supports fabric sales and exhibitions through 3D displays and mobile sharing capabilities, all powered by online cloud services. Linctex aims to empower small and medium-sized clothing enterprises with innovative tools to enhance their design and production processes.
Xinjinghe Laser Technology Development (Beijing) Co., Ltd. is a company that focuses on high-end manufacturing industries such as aerospace, navigation, and nuclear power. It specializes in complicated metal component customisation, product design and optimization, and software customization. Development and sales, technical advice and services, product remanufacturing and repair, 3D printing equipment manufacturing and sales of national high-tech businesses, is China's leading provider of metal additive/subtractive manufacturing technology comprehensive solutions.
ADA Intelligent Equipment
Series B in 2022
ADA Intelligent Equipment focuses on the design and manufacture of advanced semiconductor packaging equipment and automation solutions. The company is known for its high-precision semiconductor die bonders, flip-chip bonders, and ball bonders. Additionally, it produces wafer-level and panel packaging equipment, as well as microLED mass transfer equipment. Through its innovative technology, ADA Intelligent Equipment addresses the evolving needs of the semiconductor industry, providing essential tools for the efficient packaging of semiconductor components.
Qingyun Zhitong
Series B in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.
HjMicro
Seed Round in 2022
HjMicro is a company focused on the development of server processor chips specifically designed for the data center cloud computing market. It specializes in creating high-performance general-purpose processors based on the ARM architecture, aiming to enhance efficiency and simplify deployment in server environments. By providing advanced CPU solutions, HjMicro addresses the growing demands of data centers, contributing to the evolution of cloud computing infrastructure.
CSR Biotech
Seed Round in 2022
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.
Scientech Medical
Venture Round in 2022
Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.
Tessera Therapeutics
Series C in 2022
Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the precise insertion of therapeutic messages into the human genome. This innovative approach aims to address diseases at their source by enabling both small and large genetic alterations. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics seeks to overcome existing limitations in these fields, enhancing their efficacy and reach. Founded by Flagship Pioneering, the company aspires to establish a new category in genetic medicine that can significantly improve patient outcomes and transform healthcare.
ThreatBook
Series E in 2022
ThreatBook, established in 2015, is a prominent provider of cyber threat detection and response solutions. The company offers a sophisticated threat intelligence analysis platform that utilizes machine learning to process and analyze cyber threat data, enabling organizations to effectively defend against complex cyber attacks. ThreatBook integrates a full life cycle threat detection system with incident response capabilities, facilitating efficient protection across cloud, network, and endpoint environments. The company has received numerous accolades, including recognition on the Cybersecurity 500 list and being the only Chinese vendor featured in Gartner's Market Guide for Security Threat Intelligence Products and Services for four consecutive years. Additionally, ThreatBook ranked first in the leader quadrant growth index in Frost & Sullivan's China Threat Intelligence Market Report for 2022 and was acknowledged as a Strong Performer in Gartner Peer Insights' Voice of the Customer report for Network Detection and Response in 2023. Serving customers in various industries such as finance, energy, intelligent manufacturing, and the internet, ThreatBook is committed to enhancing security operations and reducing complexity in threat response.
Aibo Medical Robot
Seed Round in 2022
Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
UniXell Biotechnology
Seed Round in 2022
UniXell Biotechnology is a developer of cell therapy focused on addressing unmet medical needs through human pluripotent stem cell technology. The company specializes in creating innovative treatments for neurodegenerative diseases, rare diseases, and tumors. Utilizing its proprietary platforms, UniXell Biotechnology has advanced capabilities in stem cell preparation, cultivation, differentiation, and gene editing. Key technologies include reprogramming techniques, stem cell differentiation, SISBAR pedigree tracing, and high-precision gene editing, which collectively aim to provide effective therapeutic solutions for patients suffering from challenging medical conditions.
UniXell
Seed Round in 2022
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Dian Xiaomi
Series C in 2022
Dian Xiaomi is a e-commerce IT service company, focusing on providing SaaS system services for global e-commerce sellers, making it easier to "buy and sell globally". Dian Xiaomi gathers a strong domestic IT R&D team. The core members are from well-known companies such as Baidu, Tencent, and Meituan. They have 15+ years of experience in software research and development. Dian Xiaomi was established on March 26, 2014 by Jianyin Du in Longgang, Guangdong.
CYGNUSEMI
Series A in 2022
Cygnus Semi is a semiconductor chip technology company that specializes in developing solutions for 5G Internet-of-Things (IoT) applications. The company focuses on creating advanced connectivity capabilities for smart devices and smart cities. Its products are designed to enhance the performance of electronic devices, allowing manufacturers to integrate high-quality chip technology into their smart products. Through its innovations, Cygnus Semi aims to support the growing demand for enhanced connectivity in various sectors.
HemaCell
Seed Round in 2022
HemaCell is a biotechnology company specializing in cell therapy, specifically focused on regenerating hematopoietic lineages, which include blood and immune cells, through advanced in vitro techniques. Leveraging innovative stem cell reprogramming, editing, and differentiation technologies, HemaCell aims to address the critical shortage of platelets necessary for treating various diseases such as cancer, liver disease, critical illness, and hematological disorders. The company employs a unique platform that utilizes platelets as drug delivery carriers, facilitating the rapid establishment of induced pluripotent stem cells (iPSCs) and gene targeting technologies. In addition to platelet production, HemaCell is dedicated to developing novel therapeutic solutions for diseases associated with platelet abnormalities, thereby offering effective treatment options and addressing significant medical needs.
Innoscience
Series D in 2022
Innoscience (Zhuhai) Technology Co Ltd. is a semiconductor company based in Zhuhai, China, founded in 2015. It specializes in the development and production of third-generation semiconductor power electronic devices, focusing primarily on gallium nitride (GaN) technology. As an integrated device manufacturer, Innoscience produces a range of GaN products, including discrete chips, integrated circuits, wafers, and modules. These products cater to various sectors, such as consumer electronics, renewable energy, industrial applications, automotive electronics, and data centers. The company's offerings are designed to provide high-frequency performance and low on-resistance, addressing the needs of modern power semiconductor applications.
Ai Ma Biology
Angel Round in 2022
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.
ReviR Therapeutics
Seed Round in 2022
ReviR Therapeutics is a genomics-focused company that specializes in the development of RNA therapeutics aimed at treating cancer, rare genetic disorders, and infectious diseases. The company utilizes an artificial intelligence-driven platform to enhance the discovery of novel RNA-targeting medicines, thereby facilitating the delivery of innovative therapies to a wide patient population. ReviR Therapeutics combines advanced computational techniques with its expertise in RNA biology, positioning itself as a leader in the evolving field of RNA-based therapeutics.
Qingyun Zhitong
Series A in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.
Ceram Pharmaceuticals
Series A in 2022
Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.
Cloudbreak Therapeutics
Series C in 2022
Cloudbreak Therapeutics LLC, established in 2015 and based in Irvine, California, is a biotechnology company specializing in the development of ocular drugs. It focuses on repurposing approved systemic drugs for eye delivery, aiming to treat glaucoma and pterygium diseases efficiently. The company operates a capital-efficient model, utilizing contract research organizations (CROs) to maximize resources for drug development. Its business strategy involves advancing drug candidates through proof-of-concept Phase II clinical trials and subsequently out-licensing global rights for Phase III trials, registration, and commercialization.
Tianyi Hexin
Venture Round in 2022
Tianyi Hexin is a specialized developer of integrated circuits (ICs), focusing on analog, digital, hybrid, and radio frequency IC design and development. Its product portfolio includes heart rate sensors, wireless interconnect ICs, sensor front ends, data converters, ECG sensors, Bluetooth chips, Wi-Fi chips, and electric sensors. Additionally, Tianyi Hexin offers technology consulting services and intellectual property (IP) licensing to its clients.
Yunli Smart Technology
Series A in 2021
Yunli Wisdom is a digital transformation service provider for government and enterprises. It uses cloud computing, big data, Internet of Things, artificial intelligence, and blockchain as its core technologies. It focuses on government affairs, finance, transportation, manufacturing, ecological environment and other fields, and is committed to providing Application software and services empowered by new technologies.
Thousand Oaks Biopharmaceuticals
Venture Round in 2021
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.
Qixin Micro Semiconductor
Venture Round in 2021
Suzhou Qixin Micro Semiconductor Co., Ltd. was established in October 2020. Based on the ARM Cortex M4, M7 and other series of architectures, it will build high-performance and high-reliability system-on-chips for different automotive application scenarios, and develop high-end smart car controller chips. Through the use of self-developed IP, unique multi-core lock-step technologies, and the unique Six Sigma analog circuit design process for automotive-standard chips, a full series of product families covering safety standards ISO26262 ASIL-B to ASIL-D have been designed. The company's products all meet the automotive regulations AEC-Q100, functional safety standard ISO26262 and various automotive regulations reliability tests, and can be widely used in the fields of body, automotive instrumentation, safety, power, battery management and other fields. The company is mainly engaged in the research and development and sales of high-end automotive controller chips. The goal is to fill the gap in the domestic new generation of intelligent networked automotive controller chips, and is committed to becoming a leading manufacturer in the field of automotive and industrial controllers in China.
NeoCura is a biotechnology company based in Shenzhen, China, founded in 2017. It specializes in developing AI-based platforms and diagnostic tests aimed at enhancing cancer therapies. The company's offerings include NeoCura AI ALPINE, a platform for predicting tumor neoantigens, and NeoCura AI EVEREST, which validates these neoantigens to improve patient outcomes. Additionally, NeoCura TP serves as an intelligent companion diagnostic tool that forecasts treatment options for immunotherapy drugs, while NeoCura Ag focuses on patient-specific neoantigen immunotherapy. Alongside these platforms, NeoCura also provides diagnostics and medical laboratory services, leveraging AI to analyze molecular biology and clinical data to assist physicians in refining cancer diagnosis and treatment strategies.
Lehe Food
Series E in 2021
Guangdong Lehe Food Co., Ltd. is a leading provider of agricultural product distribution and supply chain management services in China. Based in Guangzhou, the company operates more than a dozen distribution centers and focuses on standardized management practices to support its growing network across the country. Lehe Food's services encompass a wide range of activities including farm operation management, agricultural planting and breeding, processing and distribution of agricultural products, and catering management. Additionally, the company offers high-end agricultural products through an online mall and provides agricultural information technology consulting. Its business operations extend across key regions such as Guangdong, Hainan, Yunnan, and Shanghai, with ongoing efforts to expand into other significant areas of the country.
Guizhou Core Long March Technology (Marching Power)
Series C in 2021
Guizhou Core Long March Technology, also known as Marching Power, is a high-tech company focused on the development of power semiconductor devices. Its product portfolio includes IGBT, coolmos, and SiC chip technologies, which are designed to operate under varying temperatures and voltages. The company's technical team comprises experts from the Chinese Academy of Sciences and skilled professionals from abroad, boasting substantial experience in product development. They oversee the entire process from chip design to manufacturing, packaging, testing, and reliability. Additionally, the company has a proficient marketing and operations management team well-versed in the semiconductor industry. Through its commitment to localizing power chip production, Guizhou Core Long March Technology aims to enable various enterprises to integrate high-quality semiconductors into their electronic products effectively.
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.
Well-Link Tech
Series B in 2021
Well-Link is a cloud rendering solutions provider with headquarters in Singapore.
Well-Link is a domestic provider of video cloud solutions. Its core technical team is a pioneer in the field of cloud games in China, with over ten years of research experience in the field. Console games, online games, Android games, and so on can all easily enter the cloud. Weiling Times has begun extensive collaboration with a number of leading domestic cloud server providers. Weiling cloud game solutions can be deployed quickly and efficiently regardless of the cloud server used.
Vision Medicals Technology
Series D in 2021
Vision Medicals Technology is a provider of advanced diagnostic services specializing in pathogenic gene detection. The company focuses on infection-precise medical treatment and employs high-throughput sequencing-based pathogen metagenomics, CRISPR-based rapid diagnosis, and other innovative technologies. By enhancing the detection capabilities for clinical pathogens, Vision Medicals aims to shorten reporting cycles and accelerate the development of the infection-accurate medical sector. It has developed proprietary pathogenic nucleic acid enrichment technology to detect micronucleic acids in clinical samples. The company leverages extensive big data in pathogen detection, supported by its genomics intelligent analysis and reporting system, to deliver precise and efficient medical diagnostics to its clients.
Changmugu Medical
Series B in 2021
Beijing Changmugu Medical Technology Co., Ltd. is a healthcare start-up that specializes in developing artificial intelligence-powered solutions for medical and surgical applications. Based in Beijing, China, the company focuses on enhancing orthopedic procedures through advanced technology. It offers a range of services including AI-assisted diagnosis, individualized surgical planning, 3D printing for patient-specific instrumentation, and post-operative evaluation. By leveraging deep learning algorithms, Changmugu Medical aims to improve the precision and safety of orthopedic surgeries, ultimately providing patients with more secure and reliable treatment options.
Singleron Biotechnologies
Series B in 2021
Singleron Biotechnologies Ltd. is a molecular diagnostic company specializing in single cell sequencing solutions. Founded in 2018 and based in Nanjing, China, with additional offices and laboratories in Suzhou, the United States, and Germany, the firm develops a range of innovative products, including the Singleron Matrix automated instrument for high-density microwell processing and GEXSCOPE single cell RNA sequencing kits. The company also offers a microfluidic chip for cell partitioning, magnetic beads for cell barcoding, and tools for data analysis such as CeleScope and SynEcoSys, which facilitate the interpretation of single cell sequencing data. Singleron provides services in single cell RNA sequencing, single nucleus RNA sequencing, and bioinformatics analysis, aiming to advance clinical diagnosis, drug development, and health management. The company collaborates with research institutes, hospitals, and pharmaceutical firms primarily in China and the United States, leveraging its exclusive IP license from Yale University to enhance its innovative capabilities in single cell analysis.
Laihua Digital Co, Ltd. is a company based in Shenzhen, China, that specializes in developing and operating a platform for video creation and customization. Founded in 2015, Laihua offers a range of services, including hand-drawn video creativity, customization, and educational resources for video makers. The platform caters to both businesses and individual users, providing professional video services alongside its unique hand-painted video capabilities.
Authing is a cloud-based identity platform that specializes in managing user identities for developers and enterprises. The platform enables clients to handle identity certification and authorization, allowing for efficient user base management and enhanced fraud prevention. Authing has established itself as a leading innovator in the Chinese SaaS market, providing essential tools that facilitate secure user management for various applications.
IASO Biotherapeutics
Series C in 2021
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company founded in 2017 and based in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies for cancer, particularly through engineered autologous and allogenic T cell therapies. These therapies are designed to enhance the immune system's ability to recognize and eliminate cancer cells, positioning IASO Biotherapeutics as a key player in the oncology field.